Defence is the Best Attack: Immuno-Oncology Breakthroughs 2025

Defence is the Best Attack: Immuno-Oncology Breakthroughs 2025 is organized by European Association for Cancer Research (EACR) and will be held from May 13 - 15, 2025 at CosmoCaixa Museum of Science, Barcelona, Catalonia, Spain.

Introduction:
We are living in very exciting times in the context of molecular oncology and in particular in the field of immuno-oncology. A deeper understanding of the molecular mechanisms involved in the interaction between the tumour and the immune system is revealing an attractive set of novel therapeutic approaches to treat cancer.

With some pronounced recent successes in this field, this is fuelling aggressive investigation, leading to new questions and challenges.

One of our most popular conferences, Defence is the Best Attack will be our fifth on this topic. Participants will learn about the most recent advances in the field of immunotherapy from the basic science to clinical studies, including the identification of novel targets. You will gain an improved understanding of the mechanisms of action of therapeutic interventions, and benefit from discussions about biomarkers of response to treatment and mechanisms of intrinsic and acquired resistance to immunotherapy.

Topics To Be Covered:

• Immune checkpoints
• Innate immune response
• Microbioma
• Immune cell therapies
• Vaccines
• Biomarkers of response to immunotherapy
• Mechanisms of resistance to immunotherapy

Lay Summary of the Conference Topic:
Immunotherapies have shown substantial clinical activity for a subset of patients with cancer. Despite these encouraging results, a large fraction of patients does not respond or fully benefit from current immunotherapies. Most tumours need to evade the immune system in order to thrive. The understanding of how cancer escapes the immune system is crucial in order to identify novel therapeutic targets and approaches to expand the population of patients that could benefit from immunotherapies. In this meeting, top scientists in the field will present the latest discoveries related to the interaction of the immune system with tumours and show the new advances in immunotherapy with the aim of discussing how these therapies can improve the lives of patients.